Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
17/10/2021 2:08 am
Meta-level question: how do you evaluate evidence for phenylpiracetam when the human data is thin and most trials are small?
What the racetam class does pharmacologically does not require the subjective effect to be large to be real.
Baseline first. Without a baseline the after picture is decoration.
The interesting question is not whether it works but for whom and at what cost.
17/10/2021 3:45 am
Test one thing at a time. It feels slower and it is the only way to learn anything. Headaches was my main issue with phenylpiracetam too.
17/10/2021 3:56 am
Where does the human data stop and the extrapolation begin? That is the whole thread.
17/10/2021 4:16 am
Read the methods section. It is the only part that says whether the conclusion is allowed to exist.